title: Selection of a suitable patient population for new antiplatelet therapy from the large clinical trial database of the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-thrombolysis in myocardial infarction 50 (TRA-2P-TIMI50) trial.
authors: From Department of Medicine (Cardiology), Tokai University School of Medicine, Kanagawa, Japan. sgoto3@mac.com.
authors: Shinichi
authors: S
authors: Goto
authors: From Department of Medicine (Cardiology), Tokai University School of Medicine, Kanagawa, Japan.
authors: Shinya
authors: S
authors: Goto
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use*; D018179:Receptors, Thrombin / Q000037:antagonists & inhibitors*; D055502:Secondary Prevention / Q000639:trends*; D020521:Stroke / Q000517:prevention & control*; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D007783:Lactones; D011725:Pyridines; D018179:Receptors, Thrombin; C530299:vorapaxar
keywords: Editorials; blood platelets; platelet aggregation inhibitors